Computing in the Age of the $1,000 Genome: Speakers from Wired, Fortune Join All-Star Lineup

Some amazing, and potentially disturbing, things could happen when scientists are able to sequence a person’s entire genome for $1,000 and in less than a day’s work. The technology is heading in that direction, fast. So I’m excited to announce today that a few more big thinkers on DNA sequencing technology and its societal implications have agreed to join Xconomy San Francisco for our next big event on Oct. 24.

Here are the new speakers that have agreed to join this half-day showcase we are planning, called “Computing in the Age of the $1,000 Genome.”

Thomas Goetz, executive editor, Wired; author, “The Decision Tree.”

David Ewing Duncan, columnist, Fortune.com; author, “Experimental Man.”

Doug Bassett, chief scientific officer, Ingenuity Systems

Ilya Kupershmidt, co-founder, VP of products, NextBio

John Wilbanks, vice president, Creative Commons

These new speakers will be matched up in a series of interactive chats throughout the day with the other speakers who were originally announced a couple weeks ago. I’ll have more to say about how these folks will be paired up as we get closer to the event. For now, here’s the rest of the lineup.

Hugh Martin, CEO, Pacific Biosciences

Cliff Reid, CEO, Complete Genomics

Atul Butte, Associate Professor, Stanford University School of Medicine

Sue Siegel, General Partner, Mohr Davidow Ventures

Ashley Dombkowski, Chief Business Officer, 23andMe

Sujal Patel, President, Isilon Storage Division, EMC

Andreas Sundquist, CEO, DNAnexus

Jim Karkanias, Senior Director, Applied Research and Technology, Microsoft Health Solutions

Rob Arnold, General Manager, Geospiza business unit, PerkinElmer

Tim Hunkapiller, Consultant, Life Technologies

This event will take place from 2 pm to 6:30 pm on Monday, Oct. 24. QB3, the group that spurs commercial applications of research from UCSF, UC Berkeley and UC Santa Cruz, has agreed to host this event at the Byers Auditorium on UCSF’s Mission Bay campus. The best deal on advance discount tickets is still available through tomorrow, and here’s where to go to get your tickets. See you there Oct. 24.

Author: Luke Timmerman

Luke is an award-winning journalist specializing in life sciences. He has served as national biotechnology editor for Xconomy and national biotechnology reporter for Bloomberg News. Luke got started covering life sciences at The Seattle Times, where he was the lead reporter on an investigation of doctors who leaked confidential information about clinical trials to investors. The story won the Scripps Howard National Journalism Award and several other national prizes. Luke holds a bachelor’s degree in journalism from the University of Wisconsin-Madison, and during the 2005-2006 academic year, he was a Knight Science Journalism Fellow at MIT.